A lot has been written about the Affordable Care Act (ACA) recently. Key provisions are kicking in over the next few months and that has left everyone asking the same question — How will the ACA affect healthcare costs in the US?  While “affordable” is right there in the title of the legislation, Ryan McGuire of Cutting Edge Information discusses another important question we should be asking which is “Will the ACA provide any relief to the increase in clinical trial costs by giving payers even more control over reimbursement decisions?”
 
http://jforcs.com/jcs/wp-content/uploads/2013/10/Macroeconomic-Forces…pdf